- Home
- APCX vs PYPD Comparison
APCX vs PYPD Comparison
Compare APCX & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APCX
- PYPD
- Stock Information
- Founded
- APCX 2006
- PYPD 2008
- Country
- APCX United States
- PYPD Israel
- Employees
- APCX N/A
- PYPD N/A
- Industry
- APCX Finance: Consumer Services
- PYPD Medical/Dental Instruments
- Sector
- APCX Finance
- PYPD Health Care
- Exchange
- APCX Nasdaq
- PYPD Nasdaq
- Market Cap
- APCX 15.8M
- PYPD 16.3M
- IPO Year
- APCX N/A
- PYPD 2020
- Fundamental
- Price
- APCX $0.56
- PYPD $3.61
- Analyst Decision
- APCX
- PYPD Buy
- Analyst Count
- APCX 0
- PYPD 2
- Target Price
- APCX N/A
- PYPD $12.00
- AVG Volume (30 Days)
- APCX 277.4K
- PYPD 4.6K
- Earning Date
- APCX 11-12-2024
- PYPD 11-06-2024
- Dividend Yield
- APCX N/A
- PYPD N/A
- EPS Growth
- APCX N/A
- PYPD N/A
- EPS
- APCX N/A
- PYPD N/A
- Revenue
- APCX $462,000.00
- PYPD N/A
- Revenue This Year
- APCX $1,315.48
- PYPD N/A
- Revenue Next Year
- APCX N/A
- PYPD N/A
- P/E Ratio
- APCX N/A
- PYPD N/A
- Revenue Growth
- APCX 3.59
- PYPD N/A
- 52 Week Low
- APCX $0.44
- PYPD $2.95
- 52 Week High
- APCX $3.36
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- APCX 33.58
- PYPD 52.69
- Support Level
- APCX $0.44
- PYPD $3.31
- Resistance Level
- APCX $0.59
- PYPD $3.75
- Average True Range (ATR)
- APCX 0.08
- PYPD 0.20
- MACD
- APCX -0.01
- PYPD 0.01
- Stochastic Oscillator
- APCX 25.90
- PYPD 61.25
About APCX AppTech Payments Corp.
AppTech Payments Corp is a FinTech company utilizing various payment processing and digital banking technologies to complement core merchant services capabilities. The company's patented and proprietary software will provide progressive and adaptable products that are available through a suite of synergistic offerings directly to merchants, banking institutions, and business enterprises. It is developing a secure digital payments and banking platform that powers commerce experiences for clients and customers. Based upon industry standards for payment and banking protocols, the company will offer standalone products and fully integrated solutions that deliver unparalleled payments, banking, and financial services experiences.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.